Literature DB >> 8440408

von Willebrand factor.

Z M Ruggeri1, J Ware.   

Abstract

von Willebrand factor is a multimeric glycoprotein essential for the normal arrest of bleeding after tissue injury (hemostasis). The molecule is present in blood, both in plasma and inside platelets, as well as in endothelial cells and the subendothelial matrix of the vessel wall. Through multiple functional domains, von Willebrand factor mediates the attachment of platelets to exposed tissues, where discontinuity of the vascular endothelium occurs, and the subsequent platelet aggregation leading to the formation of platelet thrombi. The crucial role of von Willebrand factor in platelet function is particularly apparent when hemodynamic conditions create blood flow with high shear stress, as in capillaries under physiologic conditions or in stenosed and partially occluded arteries in disease states. The involvement of von Willebrand factor in the processes that lead to acute thrombosis has attracted considerable interest on the molecular and functional biology of the protein. Indeed, understanding the mechanisms and structural bases for von Willebrand factor function may result in new and effective approaches to anti-thrombotic intervention.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8440408     DOI: 10.1096/fasebj.7.2.8440408

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  52 in total

1.  Physical characterization of a low-charge glycoform of the MUC5B mucin comprising the gel-phase of an asthmatic respiratory mucous plug.

Authors:  J K Sheehan; M Howard; P S Richardson; T Longwill; D J Thornton
Journal:  Biochem J       Date:  1999-03-01       Impact factor: 3.857

2.  In vivo imaging analysis of the interaction between unusually large von Willebrand factor multimers and platelets on the surface of vascular wall.

Authors:  Miroslaw Rybaltowski; Yuko Suzuki; Hideo Mogami; Iwona Chlebinska; Tomasz Brzoska; Aki Tanaka; Fumiaki Banno; Toshiyuki Miyata; Tetsumei Urano
Journal:  Pflugers Arch       Date:  2011-04-15       Impact factor: 3.657

Review 3.  Structure, evolution, and biology of the MUC4 mucin.

Authors:  Pallavi Chaturvedi; Ajay P Singh; Surinder K Batra
Journal:  FASEB J       Date:  2007-11-16       Impact factor: 5.191

Review 4.  von Willebrand factor.

Authors:  Z M Ruggeri
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

Review 5.  Type 1 Does the Two-Step: Type 1 Secretion Substrates with a Functional Periplasmic Intermediate.

Authors:  T Jarrod Smith; Holger Sondermann; George A O'Toole
Journal:  J Bacteriol       Date:  2018-08-24       Impact factor: 3.490

6.  Defective dimerization of von Willebrand factor subunits due to a Cys-> Arg mutation in type IID von Willebrand disease.

Authors:  R Schneppenheim; J Brassard; S Krey; U Budde; T J Kunicki; L Holmberg; J Ware; Z M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-16       Impact factor: 11.205

7.  Interaction between vWF levels and aspirin resistance in ischemic stroke patients.

Authors:  Yıldız Arslan; Tahir Kurtuluş Yoldaş; Yaşar Zorlu
Journal:  Transl Stroke Res       Date:  2013-04-25       Impact factor: 6.829

Review 8.  Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.

Authors:  Timothy C Nichols; Aaron M Dillow; Helen W G Franck; Elizabeth P Merricks; Robin A Raymer; Dwight A Bellinger; Valder R Arruda; Katherine A High
Journal:  ILAR J       Date:  2009

9.  Human von Willebrand factor gene sequences target expression to a subpopulation of endothelial cells in transgenic mice.

Authors:  W C Aird; N Jahroudi; H Weiler-Guettler; H B Rayburn; R D Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1995-05-09       Impact factor: 11.205

10.  Cardioembolic stroke in atrial fibrillation-rationale for preventive closure of the left atrial appendage.

Authors:  Boris Leithäuser; Jai-Wun Park
Journal:  Korean Circ J       Date:  2009-11-30       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.